RNA Therapeutics Part B: Progress in Molecular Biology and Translational Science, cartea 204
Dinh-Toi Chu, Van Thai Thanen Limba Engleză Hardback – 12 mar 2024
- Covers RNA therapeutics' history and future perspectives
- Discusses the processes of RNA therapeutical development
- Presents recent applications of RNA therapeutic in clinics
- Provides the advantages and disadvantages of RNA therapeutics
Din seria Progress in Molecular Biology and Translational Science
-
Preț: 587.78 lei - 32%
Preț: 726.43 lei - 32%
Preț: 734.30 lei - 29%
Preț: 732.70 lei - 32%
Preț: 684.96 lei - 32%
Preț: 606.64 lei - 32%
Preț: 684.53 lei - 27%
Preț: 896.61 lei - 29%
Preț: 634.65 lei - 32%
Preț: 691.03 lei - 32%
Preț: 685.79 lei - 32%
Preț: 607.05 lei - 33%
Preț: 680.33 lei - 32%
Preț: 687.96 lei - 32%
Preț: 683.68 lei - 32%
Preț: 688.30 lei - 33%
Preț: 679.49 lei - 32%
Preț: 694.37 lei - 32%
Preț: 685.05 lei - 24%
Preț: 681.98 lei - 32%
Preț: 691.96 lei - 28%
Preț: 731.83 lei - 5%
Preț: 714.18 lei - 29%
Preț: 713.73 lei - 33%
Preț: 682.82 lei - 33%
Preț: 682.82 lei - 32%
Preț: 684.53 lei - 32%
Preț: 688.39 lei - 9%
Preț: 685.39 lei - 5%
Preț: 712.38 lei - 32%
Preț: 693.51 lei - 9%
Preț: 687.88 lei - 32%
Preț: 690.88 lei - 29%
Preț: 689.08 lei - 29%
Preț: 687.75 lei - 28%
Preț: 696.05 lei - 33%
Preț: 688.64 lei - 33%
Preț: 683.95 lei - 32%
Preț: 690.26 lei - 33%
Preț: 685.65 lei - 32%
Preț: 693.09 lei - 32%
Preț: 692.25 lei - 33%
Preț: 685.81 lei - 29%
Preț: 687.18 lei - 32%
Preț: 691.47 lei - 24%
Preț: 774.69 lei - 24%
Preț: 776.88 lei
Preț: 690.67 lei
Preț vechi: 965.31 lei
-28% Nou
Puncte Express: 1036
Preț estimativ în valută:
132.27€ • 143.14$ • 110.26£
132.27€ • 143.14$ • 110.26£
Carte tipărită la comandă
Livrare economică 02-16 decembrie
Livrare express 02-08 noiembrie pentru 176.61 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780443235443
ISBN-10: 0443235449
Pagini: 358
Dimensiuni: 152 x 229 x 24 mm
Greutate: 0.68 kg
Editura: ELSEVIER SCIENCE
Seria Progress in Molecular Biology and Translational Science
ISBN-10: 0443235449
Pagini: 358
Dimensiuni: 152 x 229 x 24 mm
Greutate: 0.68 kg
Editura: ELSEVIER SCIENCE
Seria Progress in Molecular Biology and Translational Science
Cuprins
Preface
Dinh -Toi Chu and Van Thai Than
1. RNA therapeutics for cardiovascular disorders
Negin Parsamanesh
2. RNA therapeutics for non- alcoholic fatty liver diseases
Ali Mahmoudi
3. RNA therapeutics for kidney injury
Pouya Goleij
4. RNA therapeutics for beta-thalassemia
Hong Quan Duong
5. RNA therapeutics for infectious diseases
Van Thai Than
6. RNA therapeutics for reproductive diseases
Mehmet Firat Mutlu
7. Potential of RNA and transcriptomic data to drive drug repurposing for various diseases
Lalu Muhammad Irham
8. RNA therapeutics for glioma/glioblastoma
Amir R Afshari
9. RNA therapeutics for regenerative medicine
Dinh -Toi Chu
10. Advances in the liposome-based delivery systems for RNA therapeutics in cancer
Amir R Afshari
11. Advances in the polymeric nanoparticulate delivery systems for RNA therapeutics in cancer
Prashant Kesharwani
12. Advances in RNA therapeutics for modulation of ´undruggable´ targets
Emily Martinsen and Marie Rogne
13. Biosafety and regulatory issues of RNA therapeutics
Dinh -Toi Chu
Dinh -Toi Chu and Van Thai Than
1. RNA therapeutics for cardiovascular disorders
Negin Parsamanesh
2. RNA therapeutics for non- alcoholic fatty liver diseases
Ali Mahmoudi
3. RNA therapeutics for kidney injury
Pouya Goleij
4. RNA therapeutics for beta-thalassemia
Hong Quan Duong
5. RNA therapeutics for infectious diseases
Van Thai Than
6. RNA therapeutics for reproductive diseases
Mehmet Firat Mutlu
7. Potential of RNA and transcriptomic data to drive drug repurposing for various diseases
Lalu Muhammad Irham
8. RNA therapeutics for glioma/glioblastoma
Amir R Afshari
9. RNA therapeutics for regenerative medicine
Dinh -Toi Chu
10. Advances in the liposome-based delivery systems for RNA therapeutics in cancer
Amir R Afshari
11. Advances in the polymeric nanoparticulate delivery systems for RNA therapeutics in cancer
Prashant Kesharwani
12. Advances in RNA therapeutics for modulation of ´undruggable´ targets
Emily Martinsen and Marie Rogne
13. Biosafety and regulatory issues of RNA therapeutics
Dinh -Toi Chu